Clinical trial
A Perspective Randomized Controlled Study of the Formulation and Efficacy of Exercise Prescription for Patients With Coronary Heart Disease
NCT04923711 is registered in ClinicalTrials.gov with Jing Ma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Perspective Randomized Controlled Study of the Formulation and Efficacy of Exercise Prescription for Patients With Coronary Heart Disease
- Lead sponsor
- Jing Ma
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 1, 2021
- Completion date
- June 30, 2023
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coronary heart disease